New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

Please provide your email address to receive an email when new articles are posted on . The FDA issued a warning in 2019 about serious breathing problems associated with gabapentinoids. The study ...

Medically reviewed by Sanja Jelic, MD Key Takeaways Quitting smoking is the most important step to manage COPD.Regular exercise can help improve lung function and increase lung capacity.Breathing ...

Gabapentinoid use in patients with chronic obstructive pulmonary disease (COPD) was associated with a higher risk for severe exacerbations, a population-based cohort study from Canada indicated. Among ...

Please provide your email address to receive an email when new articles are posted on . A cough score was used to determine severity and featured questions from three validated assessments. Poorer ...

Patients with both chronic obstructive pulmonary disease (COPD) and severe pain are at an almost 40% predicted probability of falling, indicating the potential interaction between the conditions.

In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts. Dupilumab, a fully ...

Phase 2 trial launched for verekitug in COPD, expanding treatment indications for severe respiratory conditions. Top data expected in 2026. Upstream Bio, Inc. has initiated a global Phase 2 clinical ...

Both indoor and outdoor air quality impact chronic obstructive pulmonary disease (COPD), which opens up a large avenue to work with patients to improve their outcomes. For COPD patients, the adage ...